Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 2/20 | 0.39 |
| ▸ | NR1H3 | Q13133 | 5/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 4/20 | 0.38 |
| ▸ | MLYCD | O95822 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | RXRA | P19793 | 1/20 | 0.37 |
| ▸ | RXRB | P28702 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3140737 | 0.82 | CYP3A4 (0.44) | CYP3A4ACHESMN1; SMN2ALDH1A1MAPK1 | |
| SCHEMBL18896446 | 0.82 | CYP3A4 (0.44) | CYP3A4ACHESMN1; SMN2ALDH1A1MAPK1 | |
| SCHEMBL422352 | 0.81 | RXRA (0.51) | CYP3A4ACHESMN1; SMN2ALDH1A1MAPK1 | |
| SCHEMBL3431607 | 0.77 | SMN1; SMN2 (0.46) | PGRSMN1; SMN2ALDH1A1MAPK1AR | |
| SCHEMBL25207237 | 0.77 | CYP3A4 (0.47) | CYP3A4ACHESMN1; SMN2ALDH1A1MAPK1 | |
| SCHEMBL4642911 | 0.76 | CYP3A4 (0.50) | CYP3A4ACHESMN1; SMN2ALDH1A1MAPK1 | |
| SCHEMBL11278793 | 0.76 | SMN1; SMN2 (0.47) | PGRSMN1; SMN2MAPK1NR1H3NR1H2 | |
| SCHEMBL1333906 | 0.75 | LCK (0.43) | SMN1; SMN2ALDH1A1MAPK1NR1H3NR1H2 | |
| SCHEMBL14593293 | 0.75 | CES2 (0.45) | SMN1; SMN2ALDH1A1MAPK1NR1H3NR1H2 | |
| SCHEMBL13199329 | 0.74 | CYP3A4 (0.41) | CYP3A4ACHESMN1; SMN2ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8809451-B2 | Fluorinated dicarboxylic acid derivative and polymer obtained therefrom | CENTRAL GLASS COMPANY, LIMITED (JP) | 2014-08-19 | — | — | US | disclosed |
| US-8809451-B2 | Fluorinated dicarboxylic acid derivative and polymer obtained therefrom | CENTRAL GLASS COMPANY, LIMITED (JP) | 2014-08-19 | — | — | US | disclosed |
| US-20110301305-A1 | Fluorinated Dicarboxylic Acid Derivative and Polymer Obtained Therefrom | CENTRAL GLASS COMPANY, LIMITED (JP) | 2011-12-08 | — | — | US | disclosed |
| US-20110301305-A1 | Fluorinated Dicarboxylic Acid Derivative and Polymer Obtained Therefrom | CENTRAL GLASS COMPANY, LIMITED (JP) | 2011-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110301305-A1 | Fluorinated Dicarboxylic Acid Derivative and Polymer Obtained Therefrom | MCCC2, AFF2, F13A1 | CYP3A4 2766/4885ACHE 4054/4885PGR 4884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.